Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepak Verma

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Cureus|September 20, 2021
Emerging Treatments of Cardiorenal Syndrome: An Update on Pathophysiology and ManagementDeepak Verma, Amena Firoz, Sameer Krishna Prasad Garlapati, et al.
Plos Neglected Tropical Diseases|September 19, 2014
Efficacy and safety of amphotericin B emulsion versus liposomal formulation in Indian patients with visceral leishmaniasis: a randomized, open-label studyShyam Sundar, Krishna Pandey, Chandreshwar Prasad Thakur, et al.
International Journal of Surgery (London, England)|June 10, 2023
Meta-analysis of post-transcatheter aortic valve replacement outcomes in patients with cardiac amyloidosis and aortic stenosisVikash Jaiswal, Amey Joshi, Angela Ishak, et al.
Chemosphere|July 21, 2023
Ziziphus mauritiana-derived nitrogen-doped biogenic carbon dots: Eco-friendly catalysts for dye degradation and antibacterial applicationsSubramani Rajapandi, Senthilkumar Nangan, Thirumalaivasan Natesan, et al.
Blood Cells, Molecules & Diseases|April 16, 2022
BAALC gene expression tells a serious patient outcome tale in NPM1-wild type/FLT3-ITD negative cytogenetically normal-acute myeloid leukemia in adultsDeepak Verma, Rajive Kumar, M Shadab Ali, et al.
Frontiers in Pharmacology|June 30, 2025
Advances and challenges in cancer immunotherapy: mechanisms, clinical applications, and future directionsNeeharika Vatsavai, Sumeet Kaur Bhinder, Rahaman Shaik, et al.
American Journal of Blood Research|March 20, 2023
Prognostic relevance of <i>NPM1, CEBPA,</i> and <i>FLT3</i> mutations in cytogenetically normal adult AML patientsAparna Ningombam, Deepak Verma, Rajive Kumar, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|July 28, 2024
Refinement of Risk-Stratification of Cytogenetically Normal Acute Myeloid Leukemia Adult Patients by MN1 ExpressionAparna Ningombam, Deepak Verma, Rajive Kumar, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 7, 2016
Genetic variants of MAOB affect serotonin level and specific behavioral attributes to increase autism spectrum disorder (ASD) susceptibility in malesBarnali Chakraborti, Deepak Verma, Arijit Karmakar, et al.
American Journal of Blood Research|November 23, 2020
<i>MEF2C</i> expression, but not absence of bi-allelic deletion of TCR gamma chains (ABD), is a predictor of patient outcome in Indian T-acute lymphoblastic leukemiaJay Singh, Rajive Kumar, Deepak Verma, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Cureus|September 20, 2021
Emerging Treatments of Cardiorenal Syndrome: An Update on Pathophysiology and ManagementDeepak Verma, Amena Firoz, Sameer Krishna Prasad Garlapati, et al.
Plos Neglected Tropical Diseases|September 19, 2014
Efficacy and safety of amphotericin B emulsion versus liposomal formulation in Indian patients with visceral leishmaniasis: a randomized, open-label studyShyam Sundar, Krishna Pandey, Chandreshwar Prasad Thakur, et al.
International Journal of Surgery (London, England)|June 10, 2023
Meta-analysis of post-transcatheter aortic valve replacement outcomes in patients with cardiac amyloidosis and aortic stenosisVikash Jaiswal, Amey Joshi, Angela Ishak, et al.
Chemosphere|July 21, 2023
Ziziphus mauritiana-derived nitrogen-doped biogenic carbon dots: Eco-friendly catalysts for dye degradation and antibacterial applicationsSubramani Rajapandi, Senthilkumar Nangan, Thirumalaivasan Natesan, et al.
Blood Cells, Molecules & Diseases|April 16, 2022
BAALC gene expression tells a serious patient outcome tale in NPM1-wild type/FLT3-ITD negative cytogenetically normal-acute myeloid leukemia in adultsDeepak Verma, Rajive Kumar, M Shadab Ali, et al.
Frontiers in Pharmacology|June 30, 2025
Advances and challenges in cancer immunotherapy: mechanisms, clinical applications, and future directionsNeeharika Vatsavai, Sumeet Kaur Bhinder, Rahaman Shaik, et al.
American Journal of Blood Research|March 20, 2023
Prognostic relevance of <i>NPM1, CEBPA,</i> and <i>FLT3</i> mutations in cytogenetically normal adult AML patientsAparna Ningombam, Deepak Verma, Rajive Kumar, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|July 28, 2024
Refinement of Risk-Stratification of Cytogenetically Normal Acute Myeloid Leukemia Adult Patients by MN1 ExpressionAparna Ningombam, Deepak Verma, Rajive Kumar, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 7, 2016
Genetic variants of MAOB affect serotonin level and specific behavioral attributes to increase autism spectrum disorder (ASD) susceptibility in malesBarnali Chakraborti, Deepak Verma, Arijit Karmakar, et al.
American Journal of Blood Research|November 23, 2020
<i>MEF2C</i> expression, but not absence of bi-allelic deletion of TCR gamma chains (ABD), is a predictor of patient outcome in Indian T-acute lymphoblastic leukemiaJay Singh, Rajive Kumar, Deepak Verma, et al.
Pageof 9